Get startedLog in
    Picture of Acorda Therapeutics logo

    ACORQ — Acorda Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Acorda Therapeutics Posts Q3 Loss Per Share Of $2.43

    Picture of Acorda Therapeutics logoAcorda Therapeutics
    09/11/2021 21:34
    Nov 9 (Reuters) - Acorda Therapeutics Inc  ACOR.O :
    * ACORDA THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS, ADDITIONS TO LEADERSHIP TEAM
    * Q3 NON-GAAP LOSS PER SHARE $1.43
    * Q3 GAAP LOSS PER SHARE $2.43

Source text for Eikon:  ID:nBw38jxwqa 
Further company coverage:  ACOR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Acorda Therapeutics

    See all news